biotech / news / / The Economic Times
Ahmedabad-based drug maker Torrent Pharma has taken a significant early lead in the generic semaglutide market.
Torrent Pharma captured nearly 38% of the generic semaglutide market within a month of launch.
KEY POINTS
- Torrent is the only Indian company offering semaglutide in oral, reusable, and disposable injectable forms.
- Torrent's oral semaglutide uses a hybrid technology that does not violate Novo Nordisk's Rybelsus patent.
- Demand for Torrent's oral semaglutide is causing shortages at pharmacies despite recent market entry.
- Semaglutide could account for 80% of India's GLP1 market within the next 12-24 months.
COMPANIES
Summarized by Newsio from The Economic Times. How we summarize →